Logo image of ALSPW.PA

SPINEWAY (ALSPW.PA) Stock Fundamental Analysis

EPA:ALSPW - Euronext Paris - Matif - FR001400N2P2 - Common Stock - Currency: EUR

0.1396  +0 (+0.43%)

Fundamental Rating

3

Taking everything into account, ALSPW scores 3 out of 10 in our fundamental rating. ALSPW was compared to 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALSPW have multiple concerns. ALSPW is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALSPW has reported negative net income.
ALSPW had a negative operating cash flow in the past year.
ALSPW had negative earnings in each of the past 5 years.
ALSPW had a negative operating cash flow in each of the past 5 years.
ALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M

1.2 Ratios

With a Return On Assets value of -27.99%, ALSPW is not doing good in the industry: 78.13% of the companies in the same industry are doing better.
With a Return On Equity value of -37.63%, ALSPW is not doing good in the industry: 70.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -27.99%
ROE -37.63%
ROIC N/A
ROA(3y)-14.09%
ROA(5y)-32.01%
ROE(3y)-18.67%
ROE(5y)-48.1%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPW.PA Yearly ROA, ROE, ROICALSPW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400

1.3 Margins

With a decent Gross Margin value of 69.23%, ALSPW is doing good in the industry, outperforming 75.00% of the companies in the same industry.
ALSPW's Gross Margin has improved in the last couple of years.
ALSPW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.59%
GM growth 5Y26.91%
ALSPW.PA Yearly Profit, Operating, Gross MarginsALSPW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALSPW has more shares outstanding
Compared to 5 years ago, ALSPW has more shares outstanding
Compared to 1 year ago, ALSPW has a worse debt to assets ratio.
ALSPW.PA Yearly Shares OutstandingALSPW.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALSPW.PA Yearly Total Debt VS Total AssetsALSPW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

ALSPW has an Altman-Z score of 0.11. This is a bad value and indicates that ALSPW is not financially healthy and even has some risk of bankruptcy.
ALSPW has a worse Altman-Z score (0.11) than 75.00% of its industry peers.
ALSPW has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, ALSPW belongs to the top of the industry, outperforming 85.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 0.11
ROIC/WACCN/A
WACC4.31%
ALSPW.PA Yearly LT Debt VS Equity VS FCFALSPW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 2.22 indicates that ALSPW has no problem at all paying its short term obligations.
ALSPW has a better Current ratio (2.22) than 68.75% of its industry peers.
ALSPW has a Quick Ratio of 1.24. This is a normal value and indicates that ALSPW is financially healthy and should not expect problems in meeting its short term obligations.
ALSPW has a Quick ratio of 1.24. This is comparable to the rest of the industry: ALSPW outperforms 59.38% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 1.24
ALSPW.PA Yearly Current Assets VS Current LiabilitesALSPW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

ALSPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.00%, which is quite impressive.
ALSPW shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.19%.
Measured over the past years, ALSPW shows a quite strong growth in Revenue. The Revenue has been growing by 10.06% on average per year.
EPS 1Y (TTM)99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.95%
Revenue 1Y (TTM)19.19%
Revenue growth 3Y46.01%
Revenue growth 5Y10.06%
Sales Q2Q%20.31%

3.2 Future

The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALSPW will show a quite strong growth in Revenue. The Revenue will grow by 18.17% on average per year.
EPS Next Y104.49%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year-15.91%
Revenue Next 2YN/A
Revenue Next 3Y18.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPW.PA Yearly Revenue VS EstimatesALSPW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5M 10M 15M
ALSPW.PA Yearly EPS VS EstimatesALSPW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 0 -5M -10M -15M -20M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALSPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALSPW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPW.PA Price Earnings VS Forward Price EarningsALSPW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSPW.PA Per share dataALSPW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20 -30

4.3 Compensation for Growth

ALSPW's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSPW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPINEWAY

EPA:ALSPW (6/6/2025, 7:00:00 PM)

0.1396

+0 (+0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-24 2025-03-24/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap115.87K
Analysts86.67
Price Target0.36 (157.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-73.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.01
EV/EBITDA N/A
EPS(TTM)-33.46
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-7.24
FCFYN/A
OCF(TTM)-8.11
OCFYN/A
SpS14
BVpS25.61
TBVpS14.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.99%
ROE -37.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.23%
FCFM N/A
ROA(3y)-14.09%
ROA(5y)-32.01%
ROE(3y)-18.67%
ROE(5y)-48.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.59%
GM growth 5Y26.91%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 1.24
Altman-Z 0.11
F-Score4
WACC4.31%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.95%
EPS Next Y104.49%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)19.19%
Revenue growth 3Y46.01%
Revenue growth 5Y10.06%
Sales Q2Q%20.31%
Revenue Next Year-15.91%
Revenue Next 2YN/A
Revenue Next 3Y18.17%
Revenue Next 5YN/A
EBIT growth 1Y13.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.59%
EBIT Next 3Y27.22%
EBIT Next 5YN/A
FCF growth 1Y-49.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-173.02%
OCF growth 3YN/A
OCF growth 5YN/A